The U.S. FDA has granted Israeli pharma SciSparc (NASDAQ:SPRC) the green light to conduct a phase 2b study in the U.S. of its ...
Biohaven noted that SCA is a progressively debilitating neurodegenerative disease that affects some 15,000 people in the U.S. and 24,000 in Europe and the U.K., and there is no Food and Drug ...
Texas Signal published an introduction to Project 2025, also known as the Presidential Transition Project. From now until the ...
Despite showing a progression-free survival benefit, the antibody-drug conjugate did not improve overall survival in HR-positive, HER2-negative or -low breast cancer.
Biohaven is seeking to reverse the fate of its embattled experimental drug troriluzole in spinocerebellar ataxia — a ...
CMS issues Final Rule adopting some but not all proposed changes to the Medicaid Drug Rebate Program
On September 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule entitled: Misclassification of ...
In what has become a pattern of spreading vaccine misinformation, the Florida health department is telling older Floridians ...
There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...
If you purchased Lactaid milk in September you may want to check the expiration dates and batch number to see if you've been ...
The FDA granted fast track designation to EO-3021 for the treatment of advanced or metastatic gastric and gastroesophageal ...
As the FDA continues to implement digital solutions as part of its ongoing digital transformation, the integrity and accuracy of data remain paramount. DvSum's solutions will play a key role in ...
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback